奈法唑酮盐酸盐结构式
|
常用名 | 奈法唑酮盐酸盐 | 英文名 | Nefazodone hydrochloride |
|---|---|---|---|---|
| CAS号 | 82752-99-6 | 分子量 | 506.46800 | |
| 密度 | N/A | 沸点 | 599.6ºC at 760 mmHg | |
| 分子式 | C25H33Cl2N5O2 | 熔点 | 186-188ºC | |
| MSDS | 中文版 美版 | 闪点 | 316.4ºC |
奈法唑酮盐酸盐用途Nefazodone 盐酸盐是一种抗抑郁药物。 |
| 中文名 | 萘法唑酮盐酸盐 |
|---|---|
| 英文名 | nefazodone hydrochloride |
| 中文别名 | 盐酸奈法唑酮 | 氘代盐酸奈法唑酮-d5 |
| 英文别名 | 更多 |
| 描述 | Nefazodone 盐酸盐是一种抗抑郁药物。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 沸点 | 599.6ºC at 760 mmHg |
|---|---|
| 熔点 | 186-188ºC |
| 分子式 | C25H33Cl2N5O2 |
| 分子量 | 506.46800 |
| 闪点 | 316.4ºC |
| 精确质量 | 505.20100 |
| PSA | 55.53000 |
| LogP | 4.35680 |
| 外观性状 | 白色固体 |
| 储存条件 | Desiccate at RT |
| 水溶解性 | DMSO: ~11 mg/mL at 60 °C |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 安全声明 (欧洲) | 22-24/25 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
|
~63%
奈法唑酮盐酸盐 82752-99-6 |
| 文献:Mead Johnson and Company Patent: US4487773 A1, 1984 ; US 4487773 A |
| 奈法唑酮盐酸盐上游产品 2 | |
|---|---|
| 奈法唑酮盐酸盐下游产品 0 | |
|
Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity.
J. Chromatogr. A. 1374 , 122-33, (2014) The present study investigated the practical use of modern ultra-high performance liquid chromatography (UHPLC) separation techniques for drug metabolite profiling, aiming to develop a widely applicab... |
|
|
The relation between changes in patients' interpersonal impact messages and outcome in treatment for chronic depression.
J. Consult. Clin. Psychol. 80(3) , 354-64, (2012) Interpersonal theories posit that chronically depressed individuals have hostile and submissive styles in their social interactions, which may undermine their interpersonal effectiveness and maintain ... |
|
|
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.
Drug Metab. Dispos. 36(6) , 1016-29, (2008) In vitro metabolism/bioactivation of structurally related central nervous system agents nefazodone (hepatotoxin) and aripiprazole (nonhepatotoxin) were undertaken in human liver microsomes in an attem... |
| MFCD00865396 |
| 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one,hydrochloride |
| Nefazodone Hydrochloride |